AKSO HEALTH GR. (SPADR)/3 (F:8HX) — Stock Price
AKSO HEALTH GR. (SPADR)/3 (F:8HX) is currently trading at €1.62 EUR, up 0.62% today. Over the past 52 weeks, shares have ranged between €0.91 and €2.14. This page tracks AKSO HEALTH GR. (SPADR)/3's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see AKSO HEALTH GR. (SPADR)/3 cash conversion from operations.
AKSO HEALTH GR. (SPADR)/3 (8HX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks AKSO HEALTH GR. (SPADR)/3's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
AKSO HEALTH GR. (SPADR)/3 Income Statement — Revenue, Profit & Earnings by Year
AKSO HEALTH GR. (SPADR)/3's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €14.78 Million | €2.41 Million | €13.18 Million | €6.00 Million |
| Cost of Revenue | €15.06 Million | €2.29 Million | €11.91 Million | €5.39 Million |
| Gross Profit | €-281.53K | €122.13K | €1.27 Million | €605.13K |
| Research & Development | — | — | — | €421.19K |
| SG&A | €3.64 Million | €8.76 Million | €15.54 Million | €3.06 Million |
| Total Operating Expenses | €18.70 Million | €11.05 Million | €27.45 Million | €8.46 Million |
| Operating Income | €-3.92 Million | €-8.64 Million | €-14.27 Million | €-2.46 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | — | €0.00 | €0.00 | €804.14K |
| Income Before Tax | €-166.27 Million | €-9.09 Million | €-13.07 Million | €-4.01 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €-134.98 Million | €-9.46 Million | €-1.36 Million | €-16.85 Million |
AKSO HEALTH GR. (SPADR)/3 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes AKSO HEALTH GR. (SPADR)/3's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €214.95 Million | €142.02 Million | €20.46 Million | €62.81 Million |
| Total Current Assets | €196.12 Million | €142.02 Million | €20.46 Million | €62.63 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | €954.20K | €0.00 | €7.70 Million | €0.00 |
| Inventory | €190.24K | €191.20K | €1.69 Million | €7.80 Million |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €10.83 Million | €0.00 | — | — |
| Total Liabilities | €15.80 Million | €3.59 Million | €11.62 Million | €50.52 Million |
| Total Current Liabilities | €13.81 Million | €3.59 Million | €11.62 Million | €50.52 Million |
| Long-term Debt | — | — | — | — |
| Net Debt | — | — | — | — |
| Total Stockholder Equity | €199.12 Million | €138.37 Million | €8.73 Million | €12.28 Million |
| Retained Earnings | €-198.90 Million | €-63.93 Million | €-54.47 Million | €-53.11 Million |
AKSO HEALTH GR. (SPADR)/3 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how AKSO HEALTH GR. (SPADR)/3 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €1.18 Million | €1.35 Million | €-3.25 Million | €-8.63 Million |
| Capital Expenditures | €154.46K | €0.00 | €0.00 | €4.86K |
| Free Cash Flow | €1.02 Million | €1.35 Million | €-3.25 Million | €-8.63 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | €195.88 Million | €131.65 Million | €-27.51 Million | €9.10 Million |
| Dividends Paid | — | — | — | — |
| Stock-Based Compensation | — | €0.00 | €0.00 | €391.62K |
| Depreciation | €2.15 Million | €0.00 | €0.00 | €18.39K |
| Change in Cash | €90.03 Million | €77.01 Million | €-12.73 Million | €6.80 Million |
AKSO HEALTH GR. (SPADR)/3 Earnings History — EPS Actual vs. Analyst Estimates
Track AKSO HEALTH GR. (SPADR)/3's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 30, 2025 | — | — | — |
| Jun 30, 2019 | -0.45 | 0.00 | — |
| Mar 31, 2018 | 1.02 | 0.29 | +251.72% |